In this present study, we investigated the impact of pharmacologically induced microglial renewal on pathology, microglial activation, and gene expression using both the 3xTg and APP/PS1 mouse models of Alzheimer’s disease. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.